Biopharma Trend cites ImVitro


“With a team of AI, medtech, and regulatory experts, ImVitro is spearheaded by Dr. Alexandra Boussommier, a highly skilled biomedical engineer trained in Switzerland, the UK, and the US. The company’s flagship product, EMBRYOLY, is a B2B SaaS platform that harnesses computer vision and AI to enhance the imaging process in IVF fertility.”

Read the article here: “5 AI-Powered Companies Transforming the Future of Fertility Care”